INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

Moderna, Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: 6177146500

CIK: 0001682852
EIN: 813467528
State Location: MA
State of Inc.: DE

Nasdaq:MRNA

Form: SCHEDULE 13G/A

Filing Date: 24 Jul 2026
Report Date:
Accepted: 24 Jul 2026 08:10 a.m.
Accession Number: 0001088875-26-000046

Act: 34
File Number: 005-90749
Film Number: 261199210

Documents

Primary Document

Accepted: 24 Jul 2026 08:10 a.m.

0001088875-26-000046-index-headers.html

Last Modified: 24 Jul 2026 08:10 a.m.

0001088875-26-000046-index.html

Last Modified: 24 Jul 2026 08:10 a.m.

0001088875-26-000046.txt

Last Modified: 24 Jul 2026 08:10 a.m.

primary_doc.xml

Last Modified: 24 Jul 2026 08:10 a.m.